First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-... by Özgüroğlu, Mustafa, Prof, Kilickap, Saadettin, Prof, Sezer, Ahmet, Prof, Gümüş, Mahmut, Prof, Bondarenko, Igor, Prof, Gogishvili, Miranda, MD, Nechaeva, Marina, MD, Schenker, Michael, Prof, Cicin, Irfan, Prof, Ho, Gwo Fuang, Prof, Kulyaba, Yaroslav, MD, Zyuhal, Kasimova, MD, Scheusan, Roxana-Ioana, MD, Garassino, Marina Chiara, Prof, He, Xuanyao, PhD, Kaul, Manika, MD, Okoye, Emmanuel, MPH, Li, Yuntong, PhD, Li, Siyu, PhD, Pouliot, Jean-Francois, PhD, Seebach, Frank, MD, Lowy, Israel, MD, Gullo, Giuseppe, MD, Rietschel, Petra, MD

Get full text

International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic by Lee, Victor Ho-Fun, MD, Adham, Marlinda, MD, Ben Kridis, Wala, Prof, Bossi, Paolo, MD, Chen, Ming-Yuan, Prof, Chitapanarux, Imjai, Prof, Gregoire, Vincent, Prof, Hao, Sheng Po, Prof, Ho, Cheryl, MD, Ho, Gwo Fuang, Prof, Kannarunimit, Danita, MD, Kwong, Dora Lai-Wan, Prof, Lam, Ka-On, MBBS, Lam, Wai Kei Jacky, FRCS, Le, Quynh-Thu, Prof, Lee, Anne Wing-Mui, Prof, Lee, Nancy Y, Prof, Leung, To-Wai, MD, Licitra, Lisa, Prof, Lim, Darren Wan-Teck, MRCP, Lin, Jin-Ching, Prof, Loh, Kwok Seng, MBBS, Lou, Pei-Jen, Prof, Machiels, Jean-Pascal, Prof, Mai, Hai-Qiang, Prof, Mesía, Ricard, MD, Ng, Wai-Tong, Prof, Ngan, Roger Kai-Cheong, Prof, Tay, Joshua K, PhD, Tsang, Raymond King-Yin, MS, Tong, Chi-Chung, MBChB, Wang, Hung-Ming, Prof, Wee, Joseph T, MBBS

Get full text